Now, researchers have identified cellular components in mosquitoes and in humans that dengue virus uses to multiply inside these hosts after infecting them. Their findings could lead to the development of anti-dengue drugs that would inhibit one or more of these host factors, thus curtailing infection and the development of disease.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, funded the research, which was led by Mariano Garcia-Blanco, M.D., Ph.D., of Duke University Medical Center. The research appears in the current issue of the journal Nature.
"In this important study, Dr. Garcia-Blanco and his collaborators have greatly expanded the list of candidate targets for dengue drug development," says NIAID Director Anthony S. Fauci, M.D. "Their discovery should spur a better understanding of how dengue virus causes illness and open new avenues for developing specific treatments for a disease that exacts a huge global burden."
All viruses co-opt parts of the cells they invade, but dengue virus is believed to require many such host factors because it has very little of its own genetic material, says Dr. Garcia-Blanco. Yet only a handful of mosquito or human dengue virus host factors (DVHF) have been identified to date, he adds, because researchers lack the tools for determining the functions of mosquito genes.
To overcome this barrier, the researchers turned to a familiar lab animal, the fruit fly. Mosquitoes and fruit flies (Drosophila melanogaster) are closely related, and researchers have multiple tools for determining Drosophila gene functions, notes Dr. Garcia-Blanco.
The Duke researchers screened test-tube-grown Drosophila cells to find any fly gene components used by dengue virus. They employed a technique called RNA interference (RNAi) to selectively turn off, or silence, Drosophila gene segments and identify those that dengue virus requires for efficient growth. The screen turned up 116 DVHFs, of which 111 had not previously been identified as host factors.
The scientists also used RNAi and live mosquitoes to test whether silencing select DVHFs impaired the ability of dengue virus to infect the gut tissue of the insects. They found that silencing a specific mosquito gene greatly impaired the capacity of the virus to multiply in the mosquito. This finding, though preliminary, raises the possibility of selectively inhibiting dengue virus growth in mosquitoes, says Dr. Garcia-Blanco. For example, a spray containing inhibitory chemicals might be developed that would be used not to kill the mosquitoes, he says, but to make them a less effective carrier of dengue virus. Because these envisioned drugs would not target the virus directly, but rather a host factor, the virus would have less opportunity to develop drug resistance, Dr. Garcia-Blanco adds.
The 116 DVHFs discovered through the Drosophila screen included 42 that the investigators found to have counterparts in humans. Like the mosquito DVHFs, these newly discovered human DVHFs may serve as targets for new kinds of RNAi-based drugs, says Dr. Garcia-Blanco.
"Our research is motivated in part by a desire to understand how these tiny viruses manage to live in two such unrelated organisms as mosquitoes and humans," says Dr. Garcia-Blanco. "But we should also keep in the front of our minds—not the back—the magnitude of suffering caused by dengue fever to millions around the world. Our study is a big leap in terms of the amount of information we have about dengue host factors and this information could, we hope, be applied in ways that will help people."
Dr. Garcia-Blanco's collaborators included NIAID grantee George Dimopoulos, Ph.D., and others from Johns Hopkins University's Bloomberg School of Public Health. NIAID grantee Priscilla Yang, Ph.D., and others from Harvard Medical School also contributed to the new research.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
Reference: OM Sessions et al. Discovery of insect and human dengue virus host factors. Nature DOI: 10.1038/nature07969 (2009).
Visit NIAID's Dengue Fever page for more information on this disease (http://www3.niaid.nih.gov/topics/DengueFever/default.htm).
Anne A. Oplinger | EurekAlert!
Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University
ASU scientists develop new, rapid pipeline for antimicrobials
14.12.2017 | Arizona State University
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong
Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
14.12.2017 | Health and Medicine
14.12.2017 | Physics and Astronomy
14.12.2017 | Life Sciences